Victoria Garcia Albea, NP
Nurse Practitioner · Stoneham, MANPI 1770632036
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,645 of the $31,067 with a category attached, or 85.8%. 10 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 47.2% of the total. 2025 is the largest year on record at $16,739, more than ten times the $730 reported in 2021. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $647.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$15K
- Sanofi$7K
- Eli Lilly$4K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- LEO Pharma Inc.$1K
- UCB, Inc.$1K
- plus $2K from 4 others
What the payments were for
- Consulting fees$26,64586%
- Travel & lodging$3,18910%
- Food & beverage$9843%
- Education$2501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 19 | $14,671 |
| Sanofi | 11 | $6,672 |
| Eli Lilly | 6 | $4,098 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,455 |
| LEO Pharma Inc. | 2 | $1,177 |
| UCB, Inc. | 1 | $1,140 |
| Dermavant Sciences, Inc. | 2 | $1,115 |
| Pfizer | 1 | $270 |
| Johnson & Johnson | 3 | $250 |
| E.r. Squibb & Sons, L.L.C. | 2 | $220 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,067 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 20 | $406,837 |
| Dupixent PenDupilumab | 59 | $281,851 |
| Dupixent SyringeDupilumab | 18 | $111,774 |
| JubliaEfinaconazole | 11 | $14,052 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 64 | $2,891 |
| Minoxidil | 239 | $2,666 |
| Spironolactone | 117 | $2,265 |
| Hydroxychloroquine Sulfate | 34 | $2,135 |
| Pimecrolimus | 14 | $1,745 |
| Tacrolimus | 11 | $1,697 |
| Ketoconazole | 90 | $1,432 |
| Fluorouracil | 20 | $1,263 |
| Azelaic Acid | 12 | $829 |
| Metronidazole | 16 | $827 |
| Triamcinolone Acetonide | 53 | $733 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Stoneham
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Lauren BurkeBoston$26K
- Ashley HilmesBoston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.